Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial - Top-Institutions - MDSpire

Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial

  • By

  • Joseph Geraci

  • Bessi Qorri

  • Mike Tsay

  • Christian Cumbaa

  • Paul Leonczyk

  • Larry Alphs

  • Elizabeth D. Ballard

  • Carlos A. Zarate

  • Luca Pani

  • December 8, 2025

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Psychiatry
    • Clinical Trial Design
    • Artificial Intelligence
    • Neuroimaging
  • #2

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Psychiatry
    • Artificial Intelligence
    • Clinical Trial Innovation
    • Neuroinformatics
  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Psychiatry
    • Clinical Trials
    • Artificial Intelligence
    • Neuroimaging
  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Psychiatry
    • Artificial Intelligence
    • Clinical Trial Design
    • Neuroimaging
  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Psychiatry
    • Clinical Trials
    • Artificial Intelligence
    • Neuroimaging

Original Source(s)

Related Content